Drugmaker Hikma reportedly hikes price of US medicines by up to 430%

Hikma Pharmaceuticals Plc’s U.S. subsidiary has raised the price of a common diarrhea drug by more than 400 percent and is charging more for five other medicines as well, the Financial Times reported on Sunday. West-Ward Pharmaceuticals, the U.S. division of...

‘You don’t just build a bank overnight’: The digital start-up taking financial services by storm

Boden founded her British fintech start-up in 2014, shortly after she left one of Ireland’s biggest financial institutions, Allied Irish Bank, where she worked as the chief operating officer. Starling doesn’t have a single physical branch, and relies...